Found 6 matching trials
Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)
PHASE2Trial Design Patients with borderline PAH indicated by borderline mPAP valu...
Location
Thoraxclinic at the University of Heidelberg
Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
NASystemic sclerosis is a chronic autoimmune connective tissue disorder with ...
Location
University of Pennsylvania Health System
Mechanisms of Cerebrovascular Control
PHASE1The objective of this study is to identify insulin-specific cerebral blood ...
Location
University of Wisconsin, Madison
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
PHASE3The purpose of this study is to demonstrate superiority of macitentan 75 mi...
Status
Active Not Recruiting
The Impact of ERA Switching on Risk Stratification in Pulmonary Arterial Hypertension
N/APulmonary arterial hypertension (PAH) is a rare, progressive, and potential...
A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH)
PHASE3The main purpose of this study is to evaluate the safety and efficacy of ta...
Location
Children's Heathcare of Atlanta, Inc. at Egleston